![Jeroen Grasman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeroen Grasman
Directeur Financier/CFO chez
VAXART, INC.
Fortune : 330 091 $ au 30/06/2026
Profil
Jeroen Grasman is currently Chief Financial & Accounting Officer at Vaxart, Inc. since 2025.
Formerly, Mr. Grasman was Chief Financial Officer at AltruBio, Inc. from 2021 to 2025, Vice President-Finance & Operations at PACT Pharma, Inc. from 2018 to 2021, and Vice President-Finance at Intarcia Therapeutics, Inc. from 2016 to 2018.
Education includes graduate studies at the University of Groningen and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXART, INC. 0,23% | 19/05/2026 | 545 605 ( 0,23% ) | 330 091 $ | 30/06/2026 |
Postes actifs de Jeroen Grasman
| Sociétés | Poste | Début |
|---|---|---|
| VAXART, INC. | Directeur Financier/CFO | 19/05/2025 |
Anciens postes connus de Jeroen Grasman
| Sociétés | Poste | Fin |
|---|---|---|
Altrubio, Inc.
 Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Directeur Financier/CFO | 01/05/2025 |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 01/08/2021 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Directeur Financier/CFO | 01/02/2018 |
Formation de Jeroen Grasman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Altrubio, Inc.
Altrubio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunomodulators to target diseases of the immune system | Health Technology |
